go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

McNeil Healthcare (Ireland) Ltd

McNeil Healthcare (Ireland) Ltd
Airton Road, Tallaght, Dublin 24, Ireland
Telephone: +353 1 466 5200
Fax: +353 1 466 5316


Summary of Product Characteristics last updated on medicines.ie: 16/06/2010
SPC Anusol Ointment

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipients
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Anusol Ointment


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each 100 g of Anusol Ointment contains:

Zinc Oxide 10.75 g

Bismuth Subgallate 2.25 g

Balsam Peru 1.875 g

Bismuth Oxide 0.875 g

Excipients:

Wool fat 8.625g

For a full list of excipients see section 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Ointment.

A cream coloured ointment having the characteristic odour of Balsam Peru.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Anusol Ointment provides antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions. Anusol Ointment also provides lubricating properties for use with suppositories.

Indicated for the symptomatic relief of uncomplicated internal and external haemorrhoids, pruritus ani, proctitis and fissures as diagnosed by a doctor. Also indicated post-operatively in ano-rectal surgical procedures and after incision of thrombosed sclerosed ano-rectal veins as advised by a doctor.


Go to top of the page
4.2 Posology and method of administration

Adults and children 12 years and over:

Apply to the affected area at night, in the morning and after each evacuation until the condition is controlled. Thoroughly cleanse the affected area, dry and apply ointment. Anusol Ointment should be applied on a gauze dressing. For internal conditions use rectal nozzle provided and clean it after each use. Not to be taken orally.

Children under 12 years:

Not recommended, except under medical advice.

The Elderly:

As for adults


Go to top of the page
4.3 Contraindications

Anusol Ointment is contra-indicated in individuals with known hypersensitivity to any of the constituents.


Go to top of the page
4.4 Special warnings and precautions for use

Patients with rectal bleeding or blood in the stool should talk to their doctor before using this product as these conditions may be the symptom of a more serious underlying disorder.

If symptoms persist or worsen patients should consult their doctor.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known


Go to top of the page
4.6 Pregnancy and lactation

Whilst formal studies on the effect of this product during human pregnancy have not been conducted, there is no epidemiological evidence of adverse effect, either to the pregnant mother or the foetus. Due to minimal absorption of the ingredients into the systemic circulation no adverse effects are expected.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Side effects do not occur very often, occasionally a mild irritation or a burning sensation may be experienced, especially if the anoderm is not intact. Very rarely there are sensitivity reactions such as a rash. These sensations will usually stop when use of the ointment is stopped. If anything unusual happens, or the condition worsens the individual should consult their doctor.


Go to top of the page
4.9 Overdose

Treatment of a large acute overdose should include gastric lavage, purgation with magnesium sulphate and complete bed rest. If necessary, apply oxygen and give general supportive measures.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Anusol Ointment provides antiseptic, astringent and emollient properties which help to relieve discomfort associated with minor ano-rectal conditions.

Bismuth oxide is a weak astringent with supposed antiseptic properties and has a protective action on mucous membranes and raw surfaces.

Zinc Oxide is an astringent and mild antiseptic and probably owes its actions to the ability of the zinc ion to precipitate protein, but other mechanisms may be involved. Zinc Oxide is also used to absorb skin moisture and decrease friction and discourage growth of certain bacteria.

Balsam Peru has a very mild antiseptic action by virtue of its content of cinnamic and benzoic acids. It is believed to promote the growth of epithelial cells.


Go to top of the page
5.2 Pharmacokinetic properties

No pharmacokinetic data available because of minimal absorption of the ingredients.

Absorption

The active ingredients exert their therapeutic effect without being absorbed into the systemic circulation. These observations are supported by evidence from various studies and reviews.

Distribution

Not applicable

Metabolism and Elimination

Not applicable

Pharmacokinetics in Renal Impairment

Not applicable

Pharmacokinetics in the Elderly

As for adults


Go to top of the page
5.3 Preclinical safety data

Mutagenicity, Carcinogenicity and Teratogenicity

As the active ingredients exert their therapeutic effect without being absorbed into the systemic system it is not believed that mutagenicity, carcinogenicity or teratogenicity present significant risks.

Fertility

As the active ingredients exert their therapeutic effect without being absorbed into the systemic system it is not believed that there is a risk to fertility.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Magnesium Stearate

Theobroma Oil

Wool Fat

Castor Oil

Kaolin Light

White soft paraffin


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

3 years


Go to top of the page
6.4 Special precautions for storage

Do not store above 25ºC.


Go to top of the page
6.5 Nature and contents of container

25 g pack. Anusol Ointment is presented in a collapsible tube made from lacquered aluminium with a white urea-formaldehyde cap containing a melinex aluminium faced cork wad. The tube is accompanied by a plastic applicator nozzle.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

McNeil Healthcare (Ireland) Limited

Airton Road

Tallaght

Dublin 24

Ireland


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 823/23/2


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

3 April 1990/ 3 April 2010


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2010



Link to this document from your website:
http://www.medicines.ie/medicine/7265/SPC/Anusol+Ointment/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   Zinc Oxide
   Bismuth Oxide
   Bismuth Subgallate
   Balsam Peru

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo